Extended Data Fig. 1: Identifying TrPCs.
From: Unraveling the diversity and functions of tissue-resident plasma cells
a, Gating strategy for the identification of ASCs in the different tissues. PB (GFPlo) and PC (GFPhi) were identified based on the expression of Blimp1-GFP and CD138 in the bone marrow (BM), Peyer’s patches (PP), mesenteric lymph nodes (mesLN), or mandibular LNs (manLN) and Blimp1-GFP and CD98 in the genital tract (GT), colon (Co), salivary gland (SG), thymus, mammary gland (MG) or visceral adipose tissue (VAT). b, Expression profile of the top 50 most downregulated genes in ASCs compared to B cells (left) or the top 50 upregulated genes in BMPCs compared to B cells. c, Gating strategy of the mouse BMPC subpopulations. PC (CD138hi Blimp1-GFPhi) were separated in two subpopulations based on the surface expression of IgA. d, Gating strategy of the PCs (CD38+ CD138+) from human BM. RNAseq data in b are from Fig. 1.
